Tolerability and Modulatory Action of the Butyrate Releaser N-(1-carbamoyl-2-phenyl-ethyl) Butyramide

NCT04491266 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Safety Issues

Interventions

DIETARY_SUPPLEMENT: FBA
DIETARY_SUPPLEMENT: placebo

Sponsor

Federico II University